Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Drug Policy. 2007 Aug;18(4):255-61. Epub 2007 Jul 17.

Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.

Author information

  • 1INSERM U687, Saint-Maurice, France.

Abstract

AIDS-related mortality and the rate of progression to AIDS have dramatically decreased since the advent of highly active antiretroviral treatment (HAART). The overall benefit from antiretroviral HIV treatment has, however, been lesser in HIV-infected injecting drug users (IDUs) than in other patient groups (e.g. men who have sex with men). Poorer outcomes in HIV-infected IDUs are related to a variety of factors, including increased rates of non-HIV-related deaths, hepatitis C, delayed access to effective treatment, lower adherence to care and treatment regimens, continuation of illicit drug use, depression and negative life events. The available evidence strongly suggests the need for the large-scale implementation of comprehensive treatment and care strategies for IDUs that include both treatment of drug dependence and HAART.

PMID:
17689373
PMCID:
PMC2020510
DOI:
10.1016/j.drugpo.2007.05.002
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center